Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018893
Filing Date
2019-05-13
Accepted
2019-05-13 17:21:25
Documents
52
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ftsv-10q_20190331.htm 10-Q 1673617
2 EX-31.1 ftsv-ex311_10.htm EX-31.1 18107
3 EX-31.2 ftsv-ex312_8.htm EX-31.2 18527
4 EX-32.1 ftsv-ex321_9.htm EX-32.1 9456
5 EX-32.2 ftsv-ex322_6.htm EX-32.2 9431
  Complete submission text file 0001564590-19-018893.txt   4899662

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ftsv-20190331.xml EX-101.INS 929626
7 XBRL TAXONOMY EXTENSION SCHEMA ftsv-20190331.xsd EX-101.SCH 37260
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ftsv-20190331_cal.xml EX-101.CAL 40788
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ftsv-20190331_def.xml EX-101.DEF 110148
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ftsv-20190331_lab.xml EX-101.LAB 297199
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ftsv-20190331_pre.xml EX-101.PRE 208555
Mailing Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 (650) 352-4150
Forty Seven, Inc. (Filer) CIK: 0001667633 (see all company filings)

EIN.: 474065674 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38554 | Film No.: 19819462
SIC: 2834 Pharmaceutical Preparations